347 related articles for article (PubMed ID: 12731868)
21. The crystal structure of ribonuclease Rh from Rhizopus niveus at 2.0 A resolution.
Kurihara H; Nonaka T; Mitsui Y; Ohgi K; Irie M; Nakamura KT
J Mol Biol; 1996 Jan; 255(2):310-20. PubMed ID: 8551522
[TBL] [Abstract][Full Text] [Related]
22. [Structures and functions of ribonucleases].
Irie M
Yakugaku Zasshi; 1997 Sep; 117(9):561-82. PubMed ID: 9357326
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine hydrogen bonds make a large contribution to protein stability.
Pace CN; Horn G; Hebert EJ; Bechert J; Shaw K; Urbanikova L; Scholtz JM; Sevcik J
J Mol Biol; 2001 Sep; 312(2):393-404. PubMed ID: 11554795
[TBL] [Abstract][Full Text] [Related]
24. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
Biochemistry; 1999 Aug; 38(32):10287-97. PubMed ID: 10441122
[TBL] [Abstract][Full Text] [Related]
25. Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives.
Brown CJ; McNae I; Fischer PM; Walkinshaw MD
J Mol Biol; 2007 Sep; 372(1):7-15. PubMed ID: 17631896
[TBL] [Abstract][Full Text] [Related]
26. Unusual substrate specificity of a chimeric hypoxanthine-guanine phosphoribosyltransferase containing segments from the Plasmodium falciparum and human enzymes.
Sujay Subbayya IN; Sukumaran S; Shivashankar K; Balaram H
Biochem Biophys Res Commun; 2000 Jun; 272(2):596-602. PubMed ID: 10833458
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of human guanosine monophosphate reductase 2 (GMPR2) in complex with GMP.
Li J; Wei Z; Zheng M; Gu X; Deng Y; Qiu R; Chen F; Ji C; Gong W; Xie Y; Mao Y
J Mol Biol; 2006 Feb; 355(5):980-8. PubMed ID: 16359702
[TBL] [Abstract][Full Text] [Related]
28. Structure of RNase Sa2 complexes with mononucleotides--new aspects of catalytic reaction and substrate recognition.
Bauerová-Hlinková V; Dvorský R; Perecko D; Povazanec F; Sevcík J
FEBS J; 2009 Aug; 276(15):4156-68. PubMed ID: 19558492
[TBL] [Abstract][Full Text] [Related]
29. Hydrogen bonding and solvent structure in an antigen-antibody interface. Crystal structures and thermodynamic characterization of three Fv mutants complexed with lysozyme.
Fields BA; Goldbaum FA; Dall'Acqua W; Malchiodi EL; Cauerhff A; Schwarz FP; Ysern X; Poljak RJ; Mariuzza RA
Biochemistry; 1996 Dec; 35(48):15494-503. PubMed ID: 8952503
[TBL] [Abstract][Full Text] [Related]
30. Understanding substrate specificity in human and parasite phosphoribosyltransferases through calculation and experiment.
Pitera JW; Munagala NR; Wang CC; Kollman PA
Biochemistry; 1999 Aug; 38(32):10298-306. PubMed ID: 10441123
[TBL] [Abstract][Full Text] [Related]
31. A single amino acid substitution changes ribonuclease 4 from a uridine-specific to a cytidine-specific enzyme.
Hofsteenge J; Moldow C; Vicentini AM; Zelenko O; Jarai-Kote Z; Neumann U
Biochemistry; 1998 Jun; 37(26):9250-7. PubMed ID: 9649305
[TBL] [Abstract][Full Text] [Related]
32. Origin of dimeric structure in the ribonuclease superfamily.
Ciglic MI; Jackson PJ; Raillard SA; Haugg M; Jermann TM; Opitz JG; Trabesinger-Rüf N; Benner SA
Biochemistry; 1998 Mar; 37(12):4008-22. PubMed ID: 9521722
[TBL] [Abstract][Full Text] [Related]
33. Dissection of the structural and functional role of a conserved hydration site in RNase T1.
Langhorst U; Loris R; Denisov VP; Doumen J; Roose P; Maes D; Halle B; Steyaert J
Protein Sci; 1999 Apr; 8(4):722-30. PubMed ID: 10211818
[TBL] [Abstract][Full Text] [Related]
34. The three-dimensional structure of human RNase 4, unliganded and complexed with d(Up), reveals the basis for its uridine selectivity.
Terzyan SS; Peracaula R; de Llorens R; Tsushima Y; Yamada H; Seno M; Gomis-Rüth FX; Coll M
J Mol Biol; 1999 Jan; 285(1):205-14. PubMed ID: 9878400
[TBL] [Abstract][Full Text] [Related]
35. Residues involved in the catalysis, base specificity, and cytotoxicity of ribonuclease from Rana catesbeiana based upon mutagenesis and X-ray crystallography.
Leu YJ; Chern SS; Wang SC; Hsiao YY; Amiraslanov I; Liaw YC; Liao YD
J Biol Chem; 2003 Feb; 278(9):7300-9. PubMed ID: 12499382
[TBL] [Abstract][Full Text] [Related]
36. Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants.
Melet A; Marques-Soares C; Schoch GA; Macherey AC; Jaouen M; Dansette PM; Sari MA; Johnson EF; Mansuy D
Biochemistry; 2004 Dec; 43(49):15379-92. PubMed ID: 15581350
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure reveals two alternative conformations in the active site of ribonuclease Sa2.
Sevcík J; Dauter Z; Wilson KS
Acta Crystallogr D Biol Crystallogr; 2004 Jul; 60(Pt 7):1198-204. PubMed ID: 15213380
[TBL] [Abstract][Full Text] [Related]
38. Platinum complexes with NH groups on the carrier ligand and with only one guanine or hypoxanthine derivative. Informative models for assessing relative nucleobase and nucleotide hydrogen-bond interactions with amine ligands in solution.
Carlone M; Marzilli LG; Natile G
Inorg Chem; 2004 Jan; 43(2):584-92. PubMed ID: 14731020
[TBL] [Abstract][Full Text] [Related]
39. Productive and nonproductive binding to ribonuclease A: X-ray structure of two complexes with uridylyl(2',5')guanosine.
Vitagliano L; Merlino A; Zagari A; Mazzarella L
Protein Sci; 2000 Jun; 9(6):1217-25. PubMed ID: 10892814
[TBL] [Abstract][Full Text] [Related]
40. Structures of mutants of cellulase Cel48F of Clostridium cellulolyticum in complex with long hemithiocellooligosaccharides give rise to a new view of the substrate pathway during processive action.
Parsiegla G; Reverbel C; Tardif C; Driguez H; Haser R
J Mol Biol; 2008 Jan; 375(2):499-510. PubMed ID: 18035374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
